0000899243-20-004766.txt : 20200214 0000899243-20-004766.hdr.sgml : 20200214 20200214200208 ACCESSION NUMBER: 0000899243-20-004766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200212 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANIELS RONALD J CENTRAL INDEX KEY: 0001164475 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 20622915 MAIL ADDRESS: STREET 1: C/O MOORE CORPORATION LIMITED STREET 2: ONE CANTERBURY GREEN CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-12 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001164475 DANIELS RONALD J C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 1 0 0 0 Stock Option (Right to Buy) 34.65 2020-02-12 4 A 0 91554 0.00 A 2030-02-11 Common Stock 91554 91554 D The shares subject to this option vest and become exercisable in three annual installments after February 12, 2020, subject to the Reporting Person's continued service to the Issuer through each such vesting date. /s/ Tara Condon, Attorney-in-Fact 2020-02-14